Genmab A/S (GE9) Stock Statistics & Valuation Metrics

Genmab A/S has a market cap or net worth of EUR 28.63B. The enterprise value is EUR 168.19B.

Market Cap

EUR 28.63B

Enterprise Value

EUR 168.19B

Genmab A/S has 62,405,853 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

62,405,853

Owned by Insiders

―

Owned by Institutions

23.77%

Genmab A/S’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 14.13%.

Return on Equity (ROE)

0.21

Return on Assets (ROA)

0.17

Return on Invested Capital (ROIC)

14.13%

Return on Capital Employed (ROCE)

0.17

Revenue Per Employee

6.90M

Profits Per Employee

2.51M

Employee Count

3,119

Asset Turnover

0.47

Inventory Turnover

15.89

The current PE Ratio of Genmab A/S is 35.27. Genmab A/S’s PEG ratio is 0.43.

PE Ratio

35.27

PS Ratio

13.18

PB Ratio

7.01

Price to FCF

53.49

Price to Operating Cash Flow

49.16

PEG Ratio

0.43

In the last 12 months, Genmab A/S had revenue of 21.53B and earned 7.84B in profits. Earnings per share was 122.21.

Revenue

21.53B

Gross Profit

20.54B

Operating Income

6.70B

Pretax Income

9.16B

Net Income

7.84B

EBITDA

7.39B

Earnings Per Share (EPS)

122.21

In the last 12 months, operating cash flow was 6.54B and capital expenditures -199.00M, giving a free cash flow of 6.35B billion.

Operating Cash Flow

6.54B

Free Cash Flow

6.35B

Free Cash Flow per Share

54.98

Genmab A/S pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

1.87%

Earnings Yield

2.84%

Beta

0.86

52-Week Price Change

86.10%

50-Day Moving Average

344.71

200-Day Moving Average

267.56

Relative Strength Index (RSI)

66.93

Average Volume (3m)

194

Genmab A/S upcoming earnings date is Feb 24, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 05, 2026

Next Earnings Date

Feb 24, 2027

Ex-Dividend Date

―

Genmab A/S as a current ratio of 5.25, with Debt / Equity ratio of 2.80%

Current Ratio

5.25

Quick Ratio

5.24

Debt to Market Cap

0.00

Net Debt to EBITDA

-1.19

Interest Coverage Ratio

55.86

In the past 12 months, Genmab A/S has paid 1.32B in taxes.

Income Tax

1.32B

Effective Tax Rate

0.14

Genmab A/S EV to EBITDA ratio is 25.22, with an EV/FCF ratio of 50.91.

EV to Sales

12.54

EV to EBITDA

25.22

EV to Free Cash Flow

50.91

EV to Operating Cash Flow

46.78

Genmab A/S has EUR 3.23B in cash and marketable securities with EUR 143.00M in debt, giving a net cash position of EUR 3.08B billion.

Cash & Marketable Securities

EUR 3.23B

Total Debt

EUR 143.00M

Net Cash

EUR 3.08B

Net Cash Per Share

EUR 49.40

Tangible Book Value Per Share

EUR 49.98

Gross margin is 100.00%, with operating margin of 43.56%, and net profit margin of 37.36%.

Gross Margin

100.00%

Operating Margin

43.56%

Pretax Margin

48.20%

Net Profit Margin

37.36%

EBITDA Margin

49.72%

EBIT Margin

47.73%

The average price target for Genmab A/S is EUR 502.76, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target

EUR 502.76

Price Target Upside

5.16% Upside

Analyst Consensus

Strong Buy

Analyst Count

6

Revenue Growth Forecast

14.42%

EPS Growth Forecast

-52.47%